Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Chin J Nat Med. 2018 Sep;16(9):641-643. doi: 10.1016/S1875-5364(18)30103-1.
Garcinia, a kind of dry resin secreted by Garcinia hanburyi Hook. F. G., is a traditional Chinese medicine with various biological functions such as detoxification, anti-inflammatory, and anthelmintic activities. Recent studies suggest that garcinia has potential anticancer activity. Increasing evidences indicate that the main active monomer gambogic acid isolated from garcinia can inhibit the growth of various cancer cells. Neogambogic acid is an isolated compound with a similar chemical structure as gambogic acid. Preliminary studies show that the neogambogic acid can selectively inhibit the growth of various cancer cells, and has a broader antitumor activity and lower toxicity than gambogic acid. In this review, we summarize the advances made in the investigation of the anti-tumor effect of neogambogic acid in recent years.
藤黄,一种由藤黄属植物藤黄(Hook. F. G.)分泌的干性树脂,是一种具有解毒、抗炎、驱虫等多种生物功能的传统中药。最近的研究表明,藤黄具有潜在的抗癌活性。越来越多的证据表明,从藤黄中分离得到的主要活性单体藤黄酸能抑制多种癌细胞的生长。新藤黄酸是一种与藤黄酸具有相似化学结构的分离化合物。初步研究表明,新藤黄酸能选择性地抑制多种癌细胞的生长,其抗肿瘤活性比藤黄酸更广,毒性比藤黄酸更低。本文综述了近年来新藤黄酸抗肿瘤作用的研究进展。